Immuron Ltd
corporate_fare Company Profile
Immuron Ltd (NASDAQ:IMRN) is a publicly traded company in the Life Sciences sector. Wiseek monitors IMRN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Immuron Investor Presentation Maps Strategic Reset, FY26 Sales of A$7.7M, and IMM-529 Partnership Upside
- Immuron Investor Presentation Highlights FY26 Sales Growth, Cash Runway, and Partnering Strategy for CDI Asset
- Immuron Posts 6% FY26 Sales Growth, Fourth Straight Quarter of Gains
- Immuron Advances IMM-529 Partnering Strategy with Pullan Consulting Engagement
- Immuron Finalizes Small Shareholder Buyback, Cancels 3.8 Million Shares
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for IMRN, detected from its recent SEC filings · based on capital-structure filings through 2026-02-12.
Shareholder Ratification Approved · Significant Dilution Confirmed
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
IMRN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.